These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

973 related articles for article (PubMed ID: 9164544)

  • 1. Relationship of p53 and c-erbB-2 expression to histopathological features, Helicobacter pylori infection and prognosis in gastric cancer.
    Shun CT; Wu MS; Lin JT; Chen SY; Wang HP; Lee WJ; Wang TH; Chuang SM
    Hepatogastroenterology; 1997; 44(14):604-9. PubMed ID: 9164544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of p53 is associated with growth pattern and prognosis in advanced gastric cancer.
    Ichiyoshi Y; Oiwa H; Tomisaki S; Sakaguchi Y; Ohno S; Maehara Y; Sugimachi K
    Hepatogastroenterology; 1997; 44(14):546-53. PubMed ID: 9164535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of c-erb-B2 proteins in tumor and non-tumor parts of gastric adenocarcinoma--emphasis on its relation to H. pylori infection and clinicohistological characteristics.
    Wang YL; Sheu BS; Yang HB; Lin PW; Chang YC
    Hepatogastroenterology; 2002; 49(46):1172-6. PubMed ID: 12143229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Helicobacter pylori infection affects the expression of PCNA, p53, c-erbB-2 and Bcl-2 in the human gastric mucosa.
    Jorge O; Cuello Carrión FD; Jorge A; Ciocca DR
    Rev Esp Enferm Dig; 2003 Feb; 95(2):97-104, 89-96. PubMed ID: 12760717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Helicobacter pylori infection and expression of PCNA, p53, c-erbB-2 in carcinoma and precancerours lesions of the stomach].
    Lu W; Chen L; Gong H
    Zhonghua Zhong Liu Za Zhi; 1999 Mar; 21(2):125-7. PubMed ID: 11776853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in clinicopathological findings, cell kinetics and p53 expression between early gastric cancers with and without Helicobacter pylori infection.
    Mitsuhashi J; Mitomi H; Tanabe S; Koizumi W; Kikuchi S; Ojima T; Okayasu I; Saigenji K
    Hepatogastroenterology; 2004; 51(60):1636-40. PubMed ID: 15532794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urokinase system expression in gastric carcinoma: prognostic impact in an independent patient series and first evidence of predictive value in preoperative biopsy and intestinal metaplasia specimens.
    Beyer BC; Heiss MM; Simon EH; Gruetzner KU; Babic R; Jauch KW; Schildberg FW; Allgayer H
    Cancer; 2006 Mar; 106(5):1026-35. PubMed ID: 16435385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low presence of p53 abnormalities in H pylori-infected gastric mucosa and in gastric adenocarcinoma.
    Berloco P; Russo F; Cariola F; Gentile M; Giorgio P; Caruso ML; Valentini AM; Di Matteo G; Di Leo A
    J Gastroenterol; 2003; 38(1):28-36. PubMed ID: 12560919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proliferating cell nuclear antigen, p53, and c-erbB-2 expression in relation to clinicopathological variables and prognosis in cancer of the ampulla of Vater.
    Ajiki T; Kamigaki T; Hasegawa Y; Fujino Y; Suzuki Y; Takeyama Y; Ku Y; Kuroda Y
    Hepatogastroenterology; 2001; 48(41):1266-70. PubMed ID: 11677943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. c-erbB-2, p53, and nm23 proteins as prognostic factors in patients with epithelial ovarian carcinoma.
    Tomić S; Ilić Forko J; Babić D; Sundov D; Kuret S; Andelinović S
    Croat Med J; 2003 Aug; 44(4):429-34. PubMed ID: 12950146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological and molecular characteristics of Epstein-Barr virus-associated gastric carcinoma: a meta-analysis.
    Lee JH; Kim SH; Han SH; An JS; Lee ES; Kim YS
    J Gastroenterol Hepatol; 2009 Mar; 24(3):354-65. PubMed ID: 19335785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of H. pylori infection and eradication on p53, c-erbB-2 and Ki-67 in gastric mucosa.
    Brajsa K; Ferencic Z; Katicic M; Radosevic S; Presecki V; Spaventi R; Dominis M
    Hepatogastroenterology; 2006; 53(72):968-72. PubMed ID: 17153465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of cyclooxygenase-2 in primary and remnant gastric carcinoma: comparing it with p53 accumulation, Helicobacter pylori infection, and vascular endothelial growth factor expression.
    Kawabe A; Shimada Y; Uchida S; Maeda M; Yamasaki S; Kato M; Hashimoto Y; Ohshio G; Matsumoto M; Imamura M
    J Surg Oncol; 2002 Jun; 80(2):79-88. PubMed ID: 12173384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of E-cadherin, beta-catenin, CD44s and CD44v6 in gastric adenocarcinoma: relationship with lymph node metastasis.
    Joo M; Lee HK; Kang YK
    Anticancer Res; 2003; 23(2B):1581-8. PubMed ID: 12820426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The relation between Helicobacter pylori infection and p53 mutation, MG-7 antigen and AgNORs expression in the development of gastric mucosa lesions].
    Yang GB; Hu FL; Lü YY
    Zhonghua Yi Xue Za Zhi; 2003 Aug; 83(15):1331-5. PubMed ID: 12930689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multivariate analysis of DNA ploidy, p53, c-erbB-2 proteins, EGFR, and steroid hormone receptors for prediction of poor short term prognosis in breast cancer.
    Eissa S; Khalifa A; el-Gharib A; Salah N; Mohamed MK
    Anticancer Res; 1997; 17(2B):1417-23. PubMed ID: 9137508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C-erbB-2 expression is a better predictor for survival than galectin-3 or p53 in early-stage breast cancer.
    Logullo AF; Lopes AB; Nonogaki S; Soares FA; Netto MM; Nishimoto IN; Brentani MM
    Oncol Rep; 2007 Jul; 18(1):121-6. PubMed ID: 17549356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations of BAT-26 identify a subset of gastric cancer with distinct clinicopathologic features and better postoperative prognosis.
    Wu MS; Lee CW; Sheu JC; Shun CT; Wang HP; Hong RL; Lee WJ; Lin JT
    Hepatogastroenterology; 2002; 49(43):285-9. PubMed ID: 11941977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression of P53, P63, and C-erbB-2 in endometrioid adenocarcinoma and their clinicopathological significance].
    Hu WF; Liu MQ; Zhao Q
    Ai Zheng; 2004 Sep; 23(9):1021-5. PubMed ID: 15363194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of p53 predicts shorter survival in diffuse type gastric cancer.
    Lee WJ; Shun CT; Hong RL; Wu MS; Chang KJ; Chen KM
    Br J Surg; 1998 Aug; 85(8):1138-42. PubMed ID: 9718015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 49.